Gamma Medica, Inc. builds and services imaging systems based on novel technologies to improve patient health through early diagnosis of disease, improved patient treatment and by enabling new drug discovery. Gamma Medica is dedicated to leading medical imaging into a new digital era with its unique sensor readout systems. The company's core digital imaging technologies also hold great promise for a new class of solutions for the safety and security markets.In the company's Pre-Clinical Division, the Gamma Medica flagship product, the Triumph™ imaging platform, is marketed for medical research and drug development. The Triumph system combines PET (LabPET™), SPECT (X-SPECT) and CT (X-O™) modalities in the world's first tri-modality system. Gamma Medicas pre-clinical imaging products are distributed exclusively by GE Healthcare globally and in Japan by SII NanoTechnology, a Seiko company.